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Transplacental transmission of Japanese encephalitis virus (JEV) when given
intraperitoneally was demonstrated in pregnant mice as shown by isolation of the
virus from placenta and fetal tissues. Furthernore, JEV could be isolated from
the brain, liver, and spleen ofnewborn mice. The effect ofJEV at different periods
of gestation in pregnant mice was demonstrated for the first time, and the
consequences of maternal infection on fetuses and neonates were studied. JEV
infection during the 1st week of gestation caused a significantly higher number of
fetal and neonatal deaths (66%) than during the 3rd week of gestation (13.8%).
The number of abortions, stillbirths, and neonatal deaths was higher in infected
mothers than in controls. No congenital abnormalities were found in any of the
newborn mice. Sera obtained from 5-week-old healthy mice delivered by mothers
infected during the 3rd week of gestation contained JEV hemagglutination
inhibiting and immunoglobulin M antibodies. The results of these preliminary
experiments show the usefulness of mice as a model for further elucidation of
JEV infection during pregnancy and its effects on the fetus.
Although the teratogenic potential of Japa-
nese encephalitis virus (JEV) in pregnant
women is not known, Chaturvedi et al. (2) re-
ported isolation of JEV from human placenta
and fetuses during an epidemic in Uttar Pradesh,
India, in 1978. In a subsequent epidemic in 1980,
JEV was again isolated from placenta in cases
of abortion (A. Mathur et al., unpublished data).
The virus has caused many widespread epidem-
ics in India involving a large section of the pop-
ulation (7), thus posing a threat to pregnant
women in the area. Japanese workers have re-
ported an increased incidence of stillbirths and
deaths of newborn swine during a JEV epidemic
and the isolation of JEV from the brain of a
stillborn piglet (1, 8). The immune status of the
mother and the gestation period at the time of
infection are critical factors in adverse effects on
the fetus. Before an effort is made to identify
and protect patients at risk, it is essential to
establish a consistent causal relationship of ma-
ternal infection to fetal death. A suitable animal
experimental model would provide an ideal
means to validate the clinical observations and
also to study the various factors affecting trans-
placental transmission. We describe here an an-
imal model of congenital infection with JEV.
MATERIALS AND METHODS
Virus. A JEV strain (78668A) isolated from human
brain during a widespread JEV epidemic in India
during 1970 was used throughout the study. Initial
typing was done by a quick complement fixation test,
and final identification was by a neutralization test
against hyperimmune sera of JEV (Mathur et al.,
Indian J. Med. Res., in press). The virus was passed
intracerebrally (i.c.) 8 to 10 times in adult Swiss albino
mice and produced uniform sickness and 100% mor-
tality by day 6. Clinical illness and mortality were not
seen in adult mice when the virus was given intraper-
itoneally (i.p.). Infected mouse brain pools were stored
at -70°C. The infectivity titers of the brain pools,
measured by i.c. injection of serial 10-fold dilutions in
adult mice, ranged from 104l to 105 50% lethal doses
(LD50). The titers are expressed as log 10 per gram
(wet weight) of organ.
Transmission experiments. Transplacental
transmission of the virus was studied by inoculating
102 LD50 of JEV i.p. in mice on the 8th day of preg-
nancy. Localization of the virus in brain, liver, spleen,
and placenta was studied on days 1, 2, 3, 4, 5, 7, 9, and
11 after inoculation. Blood from infected mice was
collected at the same time. The tissues were collected
aseptically on different days.
Assay of virus in different organs. Different
tissues from three or more infected pregnant mice
were collected at specified intervals. The tissues were
chopped and repeatedly washed with cold Hanks bal-
anced salt solution until they were free from blood.
Fetal brain and carcasses with skin removed were
assayed for viral content. Brain tissue was collected
from stillborn mice, from newborn sick mice (within
24 h of delivery), and from some of the mice during
the neonatal period (within 30 days of birth). Liver,
spleen, and brain tissues were collected from one of
the infants. Ten percent (wt/vol) organ suspensions
were prepared in Eagle minimal essential medium
with antibiotics plus 5% heat-inactivated newbom calf
serum and centrifuged in the cold. One-day-old suck-
ling mice were inoculated i.c. with serial 10-fold dilu-
tions in minimal essential medium oftissues and blood.
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Clinical symptoms and death were noted. Virus was
identified by either a complement fixation test or a
neutralization test, using hyperimmune sera against
JEV provided by the director of the National Institute
of Virology, Pune, India.
Effect ofJEV at different periods of gestation.
Five pregnant mice were inoculated i.p. with 102 LD50
of JEV on the 5th day of pregnancy; five more were
inoculated on the 8th day, and another five were
inoculated on the 15th day. Inoculated animals were
carefully watched for abortions, stillbirths, live births,
and neonatal deaths. The total numbers of mice born,
including stillbirths, were noted. Neonatal deaths were
recorded up to 1 month after birth. Comparable con-
trol pregnant mice, inoculated with an uninfected
mouse brain suspension, were kept and studied in the
same manner.
Study of developmental anomalies. In another
set of pregnant mice, inoculated with JEV at the same
periods ofgestation as described above, developmental
anomalies were studied. Four pregnant mice were
included in each group. Two control pregnant mice
from each group were inoculated with an uninfected
brain suspension. Approximately 1 day before the
expected date of delivery, these mice were anesthe-
tised and exsanguinated. The uteri were removed and
examined for evidence of fetal abnormalities and re-
sorption.
Serological tests. Blood was collected from preg-
nant mice by cutting the tail end. Sera were examined
for hemagglutination inhibition (HI) antibodies by the
method of Clarke and Casals (3), using a sucrose
acetone-extracted, freeze-dried antigen of JEV. The
antigen was supplied by the director of the National
Institute of Virology, Pune, India. Tests for specific
immunoglobulinM (IgM) antibodies were made before
and after treatment with 2-mercaptoethanol (4).
Statistical method. Data were statisticaly ana-
lyzed by the Student t test for P values.
RESULTS
Infection in pregnant mice. We wished to
determine whether JEV crosses the placenta
and infects the fetus in mice. Eight-day-old preg-
nant mice without JEV antibodies were inocu-
lated i.p. with 102 LD50 ofJEV. No clinical illness
was observed in the inoculated mice. Figure 1
shows the distribution ofthe virus in blood, liver,
spleen, kidney, and placenta on days 1, 2, 3, 4, 5,
7, 9 and 11. The virus was recovered from the
blood on days 1 and 2 only. The virus was found
in the liver on day 2, reached a peak on day 5,
and became undetectable by day 7. Virus was
first recovered from the spleen and placenta on
day 4 and persisted throughout the study period.
Effect ofJEV infection at different stages
of gestation in mice. To determine the effect
ofJEV given at different gestation periods, mice
withoutJEV antibodies were inoculated i.p. with
102 LD50 of JEV on day 5, 8, or 15 of pregnancy.
In each group, five infected and three control
mice were observed. Of five pregnant mice in-
TIME (DAYS)
FIG. 1. JEV titers in different organs of 8-day-old
pregnant mice after intraperitoneal inoculation of
virus. Symbols: 0, Blood; U, liver; A, placenta; A,
spleen; 0, kidney. Each point represents the mean
value for three mice.
oculated during the 1st week of gestation, one
aborted and four gave birth prematurely, after
17 to 18 days of pregnancy, to a total of 21
offspring. Control pregnant mice delivered on
day 19 or 20 of pregnancy. Among the 21 babies,
4 were stillborn (21%) and 10 died during the
neonatal period (58%). There was a significant
increase in stillbirths and neonatal deaths in
these mice. Infected mice gave birth to signifi-
cantly fewer offspring than did control mice (P
< 0.025) (Table 1). No abortions were noted in
the control group. Among the mice infected dur-
ing the 2nd week of gestation, one aborted on
day 14 of gestation and four delivered at term.
The total number of infants delivered by in-
fected mothers was 35, which included 8 still-
births (23%) and 9 neonatal deaths (33%). Sta-
tistically significant (P < 0.05) differences were
observed in the number of infants delivered by
the control and infected groups (Table 1). In
pregnant mice inoculated during the 3rd week of
gestation, no evidence of abortions or stillbirths
was found. Neonatal deaths were observed in 6
of a total of 43 mice born (13.8%) (Table 1).
Developmental abnormalities. Mice in-
fected during the 1st week of pregnancy gave
birth to significantly fewer offspring than did
uninfected mice. To determine the developmen-
tal defect during gestation, 12 pregnant mice, 4
in each week of gestation, were inoculated i.p.
with 102 LD5o of JEV. The pregnant mice were
killed about 1 day before their expected date of
delivery. The fetuses were counted and exam-
ined for any gross abnormalities. Mice inocu-
lated on day 5 of gestation had 36 fetuses, of
which 6(17%) were undeveloped, 1 was resorbed,
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TABLE 1. Effects of maternal JEV infection on pregnancy at different stages ofgestation
Wk of No. of preg- No. aborted No. of stillbirths/ No. of neonat Total no. affected/gestation at Group nant mice ( total no. deaths/total (%) total no. deliveredinoculation delivered (% (%
First Virus 5 1 (20) 4/21 (21) 10/17 (58) 14/21 (66)
Control 3 0 (0) 0/27 (0) 1/27 (3.7) 1/27 (3)
Second Virus 5 1 (20) 8/35 (23) 9/27 (33) 17/35 (48.6)
Control 3 0 (0) 0/28 (0) 2/28 (7) 2/28 (7)
Third Virus 5 0 (0) 0/43 (0) 6/43 (13.8) 6/43 (13.8)
Control 3 0 (0) 0/26 (0) 1/26 (3.8) 1/26 (3.8)
and 2 were dead. JEV was isolated from the
undeveloped fetuses, whereas no virus was iso-
lated from dead fetuses. Among the mice inoc-
ulated on day 8 of gestation, one fetus was dead.
No gross abnormalities were observed in fetuses
of mice inoculated on day 8 or 15 of gestation. In
the control mice, no dead or resorbed fetuses
were found.
Virus isolation from fetus and infants.
Table 2 shows the results of virus isolation from
fetuses and infants of pregnant mice given JEV
at different periods of gestation. The virus was
isolated from the brain of 1 of 4 stillborn mice,
6 of 9 newbom sick mice, and 5 of 15 mice during
the neonatal period. The virus was isolated from
the brain, liver, and spleen of one infant mouse.
Serological studies. Virus given during the
3rd week of gestation had little effect on fetuses
or newbom infants, being rarely isolated from
these mice. To examine the effect of fetal expo-
sure to the virus, newbom infants were allowed
to grow to the age of 5 weeks, at which time
their sera were examined for HI and IgM anti-
bodies to JEV (Table 3). Of nine mice examined,
six had HI and virus-specific IgM antibodies
(Table 3). No antibodies were detected in the
sera of control mice.
DISCUSSION
This study demonstrates that an active infec-
tion occurred in pregnant mice given JEV by
the i.p. route without producing clinical illness.
A short-lived viremia was followed by replica-
tion of the virus in the liver, spleen, kidney, and
placenta. The virus replicated actively in the
placenta and was transmitted to the fetus as
shown by isolation ofJEV from fetal tissues and
newborn infants. These experiments confirmed
the transplacental transmission of JEV from
mother to fetus in mice and the utility of this
model in such studies. The pathogenesis of viral
infection in the mouse model closely parallels
JEV infection in humans, whereas in swine it
usually results in production of symptomless
viremia (10). An added advantage is the ease
with which mice can be handled.
TABLE 2. Isolation of virus from infant mice
No.
Wk of Tissue of N. from
gestation whissolaoNo. which % Iso-Group virus isola-at inoc- tion tested virus lation
ulation was iso-
lated
First Stillborn Brain 2 1 50.0
Newbor Brain 5 3 60.0
(sick)
Infant Brain 3 1 33.3
(neo-
natal pe-
riod)
Second Stillborn Brain 2 0
Newborn Brain 4 3 75.0
(sick)
Infant 5 2 40.0
(neo-
natal pe-
riod)
Infant Brain 1 1
Liver 1 1
Spleen 1 1
Third Infant Brain 7 2 29.0
(neo-
nata pe-
ri___od)
An extensive outbreak of encephalitis oc-
curred in the human population at Gorakhpur
in 1978 (Mathur et al., unpublished data). Dur-
ing this epidemic, we demonstrated the transpla-
cental transmission of JEV in humans by isolat-
ing the virus from placenta, brain, and liver
tissues of one of the aborted fetuses (2). In a
number of viral infections, the placenta is the
site of active replication of the virus, with con-
sequent spread to the fetus. Transplacental
transmission ofsome of the arboviruses has been
demonstrated in experimental mice: Colorado
tick fever (6), bluetongue (9), and Venezuelan
equine encephalitis (12) viruses.
Pregnant mice inoculated with JEV during
the 1st week of gestation suffered significantly
more fetal and neonatal deaths (66%) than did
mice inoculated during the 2nd or 3rd week of
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TABLE 3. JEVHI antibody titer before and after treatment with 2-mercaptoethanol in sera of5-week-old
mice
GpTotal No. of sera showing HI antibody titer of: No. %
run. 20 40 80 160 320 640 tive tive
A. HI antibody in 5-wk-old mice delivered by 9 3 1 1 1 6 66.6
mothers that received JEV on day 15 of
gestation
2-Mercaptoethanol-treated sera 3 2 1 6 66.6
B. 5-wk-old control mice 11
gestation. Minimal damage was seen in offspring
of mice infected during the 3rd week of preg-
nancy. Only 13.8% of the neonates died. Of the
healthy offspring of these mothers, 66.6% had
HI antibodies, including specific IgM antibodies,
in their blood, indicating exposure to JEV in
utero. This supports our earlier observation with
human females; abortions occurred after infec-
tion with JEV early in gestation, whereas women
infected near term delivered apparently healthy
babies (2). Furthermore, adult pigs are not ad-
versely affected by JEV, but sows infected early
in pregnancy deliver stillbom or abnormal young
(11). Burns (1) has observed a high incidence of
stillbirths in swine associated with the JEV ep-
idemics and epizootics in Japan. It therefore
appears that the adverse affect of JEV on the
fetus occurs when the infection is acquired early
in gestation in mice, humans, and pigs. The
adverse effects of Colorado tick fever, Venezu-
elan equine encephalitis, and bluetongue viruses
have been seen more frequently in mice inocu-
lated during the 2nd week of gestation (6, 9, 12)
whereas cytomegalovirus effects in pregnant
guinea pigs are most pronounced when the virus
is contracted late in gestation (5).
The outcome of viral infection during preg-
nancy depends on three factors: the virulence of
the virus, the period of gestation, and the im-
mune status of the mother. In this study, mice
were nonimmune. Since virus virulence was the
same for all mice, the deciding factor for fetal
infection and disease appeared to have been the
gestational period. Actively multiplying and im-
mature cells are commonly the target of the
virus during congenital infection. It appears
likely that JEV affects the immature fetus more
severely, and as the fetus matures, it becomes as
resistant to peripheral inoculation of the virus as
adult mice. Thus, virus replicates but produces
no apparent ill effects. Since the virus could be
isolated from fetuses, stillborns, and neonates, it
appears that fetal death is due to the direct
effect of JEV.
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